Jun 30, 2021

Xenon Pharmaceuticals Q2 2021 Earnings Report

Total Revenue
$2.22M
Previous year: $13.4M
-83.4%
EPS
-$0.51
Previous year: -$0.005
+10100.0%
Gross Profit
-$16.2M
Previous year: $2.66M
-706.6%
Cash and Equivalents
$82.9M
Previous year: $44.2M
+87.6%
Free Cash Flow
-$14M
Previous year: -$11.2M
+25.3%
Total Assets
$275M
Previous year: $211M
+30.4%

Xenon Pharmaceuticals

Xenon Pharmaceuticals

Xenon Pharmaceuticals Revenue by Segment